BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Nicholas Boulis\, MD\, PhD\, is a professor in the Department 
 of Neurosurgery and serves as director of the Gene and Cell Therapy for N
 eurorestoration Laboratory at Emory University School of Medicine. He is 
 also on faculty at Georgia Tech’s Parker H. Petit Institute for Bioengine
 ering and Bioscience Center for Regenerative Engineering and Medicine. Bo
 ulis graduated from Yale College and received his MD from Harvard Medical
  School in Boston\, Massachusetts. He completed his postdoctoral fellowsh
 ip and his residency in neurological surgery at University of Michigan Me
 dical Center in Ann Arbor\, Michigan. He has extensive expertise in the f
 ield of gene transfer to the nervous system. His lab pursues novel and ad
 vanced treatments for amyotrophic lateral sclerosis (ALS)\, also known as
  Lou Gehrig's disease\, as well as Parkinson’s disease\, spinal muscular 
 atrophy\, and refractory pain conditions. His lab has developed a variety
  of gene therapy vectors and has focused on the development of techniques
  for safe and accurate injection of therapeutics into the brain and spina
 l cord. Yale Zoom You are invited to a scheduled Zoom meeting. Zoom is Ya
 le’s audio and visual conferencing platform. Topic: Clinical Neuroscience
  Grand Rounds\, Department of Neurosurgery Join from PC\, Mac\, Linux\, i
 OS or Android: https://yale.zoom.us/j/91697072585?pwd=sq4tdJkfk7k678hM0oT
 D5MD2GHkSTm.1 Password: 655399 Or Telephone：203-432-9666 (2-ZOOM if on-ca
 mpus) or 646 568 7788 One Tap Mobile: +12034329666\,\, 91697072585# US (B
 ridgeport) Meeting ID: 916 9707 2585 International numbers available: htt
 ps://yale.zoom.us/u/aczoNdpjUv Program Objective(s): 1. Describe methods 
 of cell transplantation for the spinal cord. 2. Describe methods of gene 
 delivery to the spinal cord. 3. Define chemogenetics\, and its applicatio
 n to pain and spasticity. CME accreditation and disclosure statements: Ac
 creditation Statement: Yale School of Medicine is accredited by the Accre
 ditation Council for Continuing Medical Education (ACCME) to provide cont
 inuing medical education for physicians. Designation Statement: Yale Scho
 ol of Medicine designates this Live Activity for a maximum of 1.00 AMA PR
 A Category 1 Credit(s)™. Physicians should only claim credit commensurate
  with the extent of their participation in the activity. Disclosure Polic
 y: It is the policy of Yale School of Medicine\, Continuing Medical Educa
 tion (CME)\, to ensure balance\, independence\, objectivity\, and scienti
 fic rigor in all its educational programs. All individuals involved in th
 e development and presentation of Accredited Continuing Education activit
 ies are required to disclose all financial relationship(s) with ineligibl
 e companies (those whose primary business is producing\, marketing\, sell
 ing\, re-selling\, or distributing healthcare products used by or on pati
 ents) that has occurred within the past 24 months\; and the opportunity t
 o affect the content of CME about the products or services of the commerc
 ial interests. This information is disclosed to all activity participants
  prior to the commencement of the educational activity. Mitigation of Fin
 ancial Relationships Statement: Yale CME adheres to the ACCME’s Standards
  for Integrity and Independence in Accredited Continuing Education. Any i
 ndividuals in a position to control the content of a CE activity\, includ
 ing faculty\, planners\, reviewers or others are required to disclose all
  relevant financial relationships with ineligible companies. All relevant
  conflicts of interest have been mitigated prior to the commencement of t
 he activity.\n\nSpeaker:\nNicholas Boulis\, MD\, PhD\n\nAdmission:\nFree\
 n\nDetails URL:\nhttps://medicine.yale.edu/event/clinical-neuroscience-gr
 and-roundssoct82026-copy/\n
DTEND;TZID=America/New_York:20261008T180000
DTSTAMP:20261001T013129Z
DTSTART;TZID=America/New_York:20261008T170000
SEQUENCE:0
STATUS:Confirmed
SUMMARY:Clinical Neuroscience Grand Rounds
UID:c88c22ed-05ad-4e63-be0b-e7c19436fb00
END:VEVENT
END:VCALENDAR
